Osteosynthesis Devices Market Size to Hit US$ 16.7 Billion by 2032 | With a 5.97% CAGR

IMARC Group's report titled "Osteosynthesis Devices Market by Type (Internal, External), Material (Non-Degradable, Degradable), Fracture Type (Patella, Tibia or Fibula or Ankle, Clavicle, Scapula or Humerus, Radius or Ulna, Hand, Wrist, Vertebral Column, Pelvis, Hip, Femur, Foot Bones, and Others), End User (Hospitals, Orthopedic Specialist Clinics, and Others), and Region 2024-2032". The global osteosynthesis devices market size reached US$ 9.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.97% during 2024-2032.

𝗚𝗿𝗮𝗯 𝗮 𝘀𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/osteosynthesis-devices-market/requestsample

𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗔𝗳𝗳𝗲𝗰𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗿𝗼𝘄𝘁𝗵 𝗼𝗳 𝘁𝗵𝗲 𝗢𝘀𝘁𝗲𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆:

● 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗜𝗻𝗰𝗶𝗱𝗲𝗻𝗰𝗲 𝗼𝗳 𝗕𝗼𝗻𝗲 𝗙𝗿𝗮𝗰𝘁𝘂𝗿𝗲𝘀:

The rising prevalence of bone fractures due to osteoporosis, falls, and degenerative bone diseases is propelling the growth of the market. As people are aging, their bones are becoming more fragile, increasing the likelihood of fractures even with minor trauma. Besides this, urbanization and changes in lifestyle are leading to an increase in accidents, sports injuries, and other trauma-related incidents, further contributing to the incidence of bone fractures. Activities like sports and recreational pursuits often involve physical strain and accidents, which can result in fractures.

● 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀:

Innovations in engineering and design are leading to the development of osteosynthesis devices that offer enhanced biomechanical properties and better anatomical fit. Advancements, such as locking plates, intramedullary nails, and anatomically contoured implants, improve stability and promote faster healing. The use of advanced materials like titanium alloys, stainless steel, and biocompatible polymers is revolutionizing the field of osteosynthesis. These materials offer superior strength, corrosion resistance, and biocompatibility, reducing the risk of implant failure and enhancing patient outcomes.

● 𝗚𝗿𝗼𝘄𝗶𝗻𝗴 𝗣𝗿𝗲𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝘀 𝗳𝗼𝗿 𝗠𝗶𝗻𝗶𝗺𝗮𝗹𝗹𝘆 𝗜𝗻𝘃𝗮𝘀𝗶𝘃𝗲 (𝗠𝗜) 𝗣𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀:

Minimally invasive (MI) procedures involve smaller incisions compared to traditional open surgeries. This results in less disruption to surrounding soft tissues, leading to reduced pain, faster recovery times, and improved cosmetic outcomes for patients. MI techniques are also associated with lower rates of complications, such as infection, blood loss, and wound healing problems. This makes them particularly attractive for patients with comorbidities or those at higher risk of surgical complications.

𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗢𝘀𝘁𝗲𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆:

● Arthrex Inc.
● B. Braun Melsungen AG
● Globus Medical Inc.
● GS Medical USA
● Johnson & Johnson
● Life Spine Inc.
● MicroPort Scientific Corporation
● Neosteo SAS
● Precision Spine Inc.
● Smith & Nephew plc
● Stryker Corporation
● Zimmer Biomet

𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗳𝘂𝗹𝗹 𝗿𝗲𝗽𝗼𝗿𝘁 𝘄𝗶𝘁𝗵 𝘁𝗮𝗯𝗹𝗲 𝗼𝗳 𝗰𝗼𝗻𝘁𝗲𝗻𝘁𝘀: https://www.imarcgroup.com/osteosynthesis-devices-market

𝗢𝘀𝘁𝗲𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

𝗕𝘆 𝗧𝘆𝗽𝗲:

● Internal
● Screw and Plates
● Wires and Pins
● Intramedullary Rods and Nails
● Spinal Fixation Devices
● External
● Fracture Fixation
● Bone Lengthening

Internal represents the largest segment on account of the utilization of internal fixation devices, such as plates, screws, and nails, for stabilizing fractures and offering superior biomechanical stability compared to external fixation methods.

𝗕𝘆 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹:

● Non-Degradable
● Degradable

Non-degradable accounts for the majority of the market share owing to its long-term mechanical support and stability to fractured bones, making it a preferred choice in orthopedic surgery.

𝗕𝘆 𝗙𝗿𝗮𝗰𝘁𝘂𝗿𝗲 𝗧𝘆𝗽𝗲:

● Patella, Tibia or Fibula or Ankle
● Clavicle, Scapula or Humerus
● Radius or Ulna
● Hand, Wrist
● Vertebral Column
● Pelvis
● Hip
● Femur
● Foot Bones
● Others

Patella, tibia, or fibula, and ankle exhibit a clear dominance in the market due to their high incidence rates and the necessity for effective stabilization to ensure proper healing and functional recovery.

𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿:

● Hospitals
● Orthopedic Specialist Clinics
● Others

Hospitals hold the biggest market share as they serve as primary facilities for orthopedic surgeries and trauma care, where a significant volume of osteosynthesis procedures are performed regularly, necessitating the use of osteosynthesis devices.

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:

● North America (United States, Canada)
● Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
● Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
● Latin America (Brazil, Mexico, Others)
● Middle East and Africa

North America enjoys the leading position in the osteosynthesis devices market, driven by well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and a growing prevalence of orthopedic conditions in the region.

𝗚𝗹𝗼𝗯𝗮𝗹 𝗢𝘀𝘁𝗲𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀:

There is a growing emphasis on the use of biocompatible materials in osteosynthesis devices to minimize the risk of adverse reactions and improve patient safety. This includes the development of implants made from titanium alloys, stainless steel, and biodegradable polymers. In addition, healthcare providers are focusing on delivering value-based care, emphasizing improved patient outcomes and cost-effectiveness. This is leading to greater scrutiny of the clinical and economic outcomes associated with different osteosynthesis devices, influencing purchasing decisions.

Furthermore, digital technologies, such as 3D printing, robotic-assisted surgery, and smart implants, are integrated into osteosynthesis devices, enabling personalized treatments, real-time monitoring, and enhanced surgical precision.

𝗧𝗿𝗲𝗻𝗱𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝗕𝘆 𝗜𝗠𝗔𝗥𝗖 𝗚𝗿𝗼𝘂𝗽:

Non-Alcoholic Steatohepatitis Nash Market: https://www.imarcgroup.com/non-alcoholic-steatohepatitis-market

Personal Emergency Response System Market: https://www.imarcgroup.com/personal-emergency-response-system-market

Animal Wound Care Market: https://www.imarcgroup.com/animal-wound-care-market

Genotyping Market: https://www.imarcgroup.com/genotyping-market

Energy Gums Market: https://www.imarcgroup.com/energy-gums-market

Peripheral Artery Disease Market: https://www.imarcgroup.com/peripheral-artery-disease-market

Vessel Sealing Devices Market: https://www.imarcgroup.com/vessel-sealing-devices-market

Cancer Biomarkers Market: https://www.imarcgroup.com/cancer-biomarkers-market

𝗡𝗼𝘁𝗲: 𝗜𝗳 𝘆𝗼𝘂 𝗻𝗲𝗲𝗱 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗮𝘁 𝗶𝘀 𝗻𝗼𝘁 𝗰𝘂𝗿𝗿𝗲𝗻𝘁𝗹𝘆 𝘄𝗶𝘁𝗵𝗶𝗻 𝘁𝗵𝗲 𝘀𝗰𝗼𝗽𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗿𝗲𝗽𝗼𝗿𝘁, 𝘄𝗲 𝘄𝗶𝗹𝗹 𝗽𝗿𝗼𝘃𝗶𝗱𝗲 𝗶𝘁 𝘁𝗼 𝘆𝗼𝘂 𝗮𝘀 𝗮 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝗦:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.